Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Cytotoxic profile of CD3+CD20+T cells in progressive multiple sclerosis

Full text
Author(s):
Boldrini, Vinicius O. [1, 2, 3] ; Quintiliano, Raphael P. S. [3] ; Silva, Lucas S. [4] ; Damasceno, Alfredo [4] ; Santos, Leonilda M. B. [1, 2, 3] ; Farias, Alessandro S. [1, 2, 3, 5]
Total Authors: 6
Affiliation:
[1] Natl Inst Sci & Technol Neuroimmunomodulat INCT N, Rio De Janeiro - Brazil
[2] Univ Estadual Campinas, Inst Biol, Dept Genet Microbiol & Immunol, Autoimmune Res Lab, Campinas - Brazil
[3] Univ Estadual Campinas, Inst Biol, Dept Genet Evolut Microbiol & Immunol, Neuroimmunol Unit, Campinas - Brazil
[4] Univ Estadual Campinas, Dept Neurol, Campinas - Brazil
[5] Expt Med Res Cluster, Div Immune Mediated Dis, Campinas - Brazil
Total Affiliations: 5
Document type: Letter
Source: MULTIPLE SCLEROSIS AND RELATED DISORDERS; v. 52, JUL 2021.
Web of Science Citations: 0
Abstract

Recently, it was shown that highly effective anti-CD20 therapies used for MS patients not only deplete CD20+ B cells, but also a small subset of T cells expressing CD20 surface marker (CD3+CD20+ T cells). Here we demonstrated that, in progressive MS patients, CD3+CD20+ T cells share the ability to express cytotoxic factors such as perforin and serine-protease granzyme-B (GzmB), classically associated with CD8+ T cells functionality. Beyond it, cluster analyses show that a set of activation markers and transcriptional factors related with CD8 effector program are also expressed in CD3+CD20+ T cells. Further characterization of surface and functional markers from CD3+CD20+ T subsets may be helpful for development of new therapeutic strategies mainly for progressive MS patients, as well as for assessing pathophysiological effects of highly effective anti-CD20 therapies. (AU)

FAPESP's process: 17/21363-5 - Regulation of JAK/STAT/SOCS in the ontogen of IFNg-producing cells derivated from encephalitogenic Th17 cells during the clinical evolution of experimental autoimmune encephalomyelitis
Grantee:Alessandro dos Santos Farias
Support Opportunities: Regular Research Grants
FAPESP's process: 19/06372-3 - Multiparametric flow cytometry
Grantee:Alessandro dos Santos Farias
Support Opportunities: Multi-user Equipment Program
FAPESP's process: 14/26431-0 - Multiple sclerosis, clinical study, neuropsychological, immunological, biomarkers and modifying-disease new drugs
Grantee:Leonilda Maria Barbosa dos Santos
Support Opportunities: Research Projects - Thematic Grants